Key result
Early oral anticoagulation (0-4 days) after acute ischaemic stroke or TIA associated with atrial fibrillation was not associated with a significant difference in the 90-day composite rate of stroke, TIA, or death compared with late anticoagulation (adjusted OR 1.17 for late vs early, p=0.736).
Why the study?
The optimal time to start oral anticoagulation in patients with ischaemic stroke due to non-valvular atrial fibrillation is unknown.
Does early oral anticoagulant initiation reduce the composite outcome of TIA, stroke, or death in patients with ischaemic stroke or TIA and non-valvular atrial fibrillation?
Population
1355 patients with ischaemic stroke or TIA and AF
Comparison
Early (0-4 days) vs later (≥5 days or never started) OAC initiation
Design
Post hoc analysis of a prospective multicentre observational inception cohort study
Follow-up
90 days
Authors
Loading...
No 90-day outcome difference seen with early versus late anticoagulation; leaves optimal timing unresolved pending randomized trials.
Cohort (n=1,355)
Yes
Does early oral anticoagulant initiation reduce the composite outcome of TIA, stroke, or death in patients with ischaemic stroke or TIA and non-valvular atrial fibrillation?
Odds Ratio: 1.17 (95% CI 0.48–2.84)
Absolute Event Rate: 2% vs 5%
p-value: p=0.736
Early initiation of oral anticoagulation (0-4 days) after acute ischemic stroke or TIA in patients with atrial fibrillation was not associated with a significant difference in 90-day composite outcomes compared to late initiation.
Wilson et al. (2018) conducted a cohort in Ischaemic stroke or transient ischaemic attack (TIA) with atrial fibrillation (n=1,355). Early oral anticoagulation (0-4 days) vs. Late oral anticoagulation (≥5 days or never started) was evaluated on Composite of TIA, stroke (ischaemic stroke or intracranial haemorrhage) or death within 90 days (adjusted OR 1.17, 95% CI 0.48 to 2.84, p=0.736). Early oral anticoagulation (0-4 days) after acute ischaemic stroke or TIA associated with atrial fibrillation was not associated with a significant difference in the 90-day composite rate of stroke, TIA, or death compared with late anticoagulation (adjusted OR 1.17 for late vs early, p=0.736).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: